Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.

Biotechnology

Apogee Therapeutics

Michael Henderson

Jeff Hartness

Rebecca Dabora, PhD

Lukas Dillinger

Tim Piringer

Elizabeth W.

Nimish Shah

Kristine Nograles

Mehrak Kiankarimi

Jordan Adajar

Wendy Aspden-Curran

Jane Pritchett Henderson

Emily K Cox

Drew Badger

Dan Mulreany

Carl Dambkowski

Leadership Team

Clinical Operations and Development

People and Talent Team

Business and Strategy

Regulatory Affairs and Quality Assurance Team

Teams at Apogee Therapeutics

Leadership Team

Clinical Operations and Development

People and Talent Team

Business and Strategy

Regulatory Affairs and Quality Assurance Team